| Financial Year |
March 31 2023 |
| Monetary Funds |
421,225,562.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,776,501.14 |
| Accounts Receivable |
369,340,469.90 |
| Advances to Suppliers |
63,840,662.05 |
| Other Receivables |
256,597,731.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
493,313,793.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
54,085,880.31 |
| Total Current Assets |
1,825,194,465.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
652,939,086.22 |
| Investment Properties |
13,518,871.19 |
| Fixed Assetes |
2,078,009,228.41 |
| Under-construction Projects |
119,831,562.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
276,999,268.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,771,293.01 |
| Deferred Income Tax Assets |
40,816,028.70 |
| Other Non-Current Assets |
76,139,147.09 |
| Sub-Total of Non-Current Assets |
3,303,124,547.02 |
| Total Assets |
5,128,319,012.19 |
| Short-Term Loans |
630,766,388.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
143,592,039.88 |
| Accounts Payable |
391,543,191.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,103,856.34 |
| Taxes Payable |
5,300,575.32 |
| Interest Payable |
20,767,764.92 |
| Dividend Payable |
-- |
| Other payables |
47,855,134.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,493,174.84 |
| Other Current Liabilities |
76,207,465.30 |
| Sub-Total of Current Liabilities |
1,388,768,016.95 |
| Long-term Loans |
1,009,304,211.58 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
51,972,050.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,125,164,467.64 |
| Total Liabilities |
2,513,932,484.59 |
| Paid-In Capital(Or Share Stock) |
629,481,713.00 |
| Capital Surplus |
1,083,121,752.47 |
| Surplus Reserve |
61,607,809.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
775,010,608.24 |
| Minority Stockholder's Interest |
64,678,685.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,549,707,841.93 |
| Owner's Equity（Stockholder's Equity） |
2,614,386,527.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,128,319,012.19 |
